It’s the Indian version of Novavax which is already available in the European market.
Covovax is a “SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine” administered intramuscularly, preferably in the deltoid muscle. It is the 2nd one manufactured by Serum Institute of India (SII) besides the Oxford-AstraZeneca vaccine Covishield.
Children aged 12 years and above can receive their Covovax doses at private centres.
Recommended interval between 2 doses (0.5 mL each) are 21 days.
Response Time to FORMs:
Within 6 hours on best effort basis